3dMD Announces Four New Healthcare Clients and a New Chief Scientific Advisor
Date: May 6, 2003
Source: 3dMD Press Release
Article: 3dMD (www.3dMD.com), a pioneer in 3-D surface imaging, today announced that four US-based centers of clinical excellence and research have purchased its 3D surface capture systems and the appointment of a Chief Scientific Advisor.
3dMD is excited to report continued momentum for its 3-D surface capture and application in healthcare. During the past few months, the following organizations have purchased systems from 3dMD.
• Walter Reed Army Medical Center (Washington, DC), which is the US Army’s largest healthcare facility and one of the largest in the Department of Defense, for multidisciplinary use with a special focus on oral/craniofacial and truncal reconstruction application
• University of Texas M.D. Anderson Cancer Center (Houston, TX) for breast reconstruction research, surgical planning, and outcomes assessment
• University Oklahoma Medical Center (Oklahoma City, OK) for cleft/craniofacial research and surgical treatment planning
• Georgia Technology Institute (Atlanta, GA) for craniofacial research
“3dMD’s imaging technology will help us track and compare the facial changes that occur with surgical intervention, as well as also enhancing ongoing growth studies in respect to soft tissue changes,” stated Dr. Kevin S. Smith, Co-Director of the Keys Cleft Palate – Craniofacial Clinic and Associate Professor Oral and Maxillofacial Surgery, Colleges of Dentistry and Medicine, University of Oklahoma. Dr. Smith works extensively with cleft and craniofacial reconstruction and was the first surgeon in Oklahoma to perform facial distraction osteogenesis.
The company appointed a new Chief Scientific Advisor, Dr Ioannis A. Kakadiaris, who is currently an Assistant Professor in the Department of Computer Science at the University of Houston, Co-Director of the Visual Computing Lab, and Director of the Division of Bioimaging and Biocomputation of the UH Institute for Digital Informatics and Analysis.
“During the past two years, 3dMD’s systems have played an important role in assisting our customers with research quantification and, as a result, we anticipate our customers not only publishing additional research papers, but more importantly developing compatible software such as Morpho Studio by OrthoVisage,” said Chris Lane, 3dMD’s CEO. “With this type of proven academic acceptance around the world, 3dMD is seeing a rapid acceleration in adoption for our unique technology, especially in the US.”